Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Murphy JA, et al
But in practice, and especially with regard to synthetic and recombinant peptide forms, there are some considerable potential safety concerns: Immunogenicity Most notably, per a 2020 assessment on therapeutic peptide safety, synthetic and recombinant peptides pose the risk of immunogenicity the ability of a substance to provoke an immune response.15 An immunogenicity-inducing peptide, when introduced to the body, would cause the bodys immune system to perceive the peptide not as a medication but as a threat
These include Alzheimers disease, Parkinsons disease and alcohol use disorder (Figure 2)
Representative image
Whether youre new to peptides or ready to take the next step, were here to support you with expert care and personalized plans
